The American Society of Hematology (ASH) Meeting, December 5-9, 1997

This Conrad Notes report on the American Society of Hematology (ASH) Meeting presents succinct analysis of key presentations.

• Antiangiogenesis Therapy in Cancer - J. Folkman


• Does Low Molecular Weight Heparin Prolong Cancer Patient Survival? - A. Kakkar


• Total Therapy of Acute Myeloid Leukemia (AML) - R. Powles


• Idarubicin (IDA) for Older Non-Hodgkins Lymphoma Patients - F. Cabanillas


• Nutrition and Survival After Bone Marrow Transplant - M. E. Hill


• Trends in Blood Component Usage - M. A. Popovsky


• Who Should Pay for Basic Research and Clinical Trials? - J. Stossel


• CD34+ Cell Transplants Reduce Hospital Costs - J. Glaspy